Literature DB >> 8825572

Limb-sparing surgery versus amputation for dogs with bone tumors.

R C Straw1, S J Withrow.   

Abstract

Recently, limb-sparing surgeries have been used in the treatment of dogs with malignant bone tumors. These new techniques are fraught with potential complications. As amputation is a time-honored technique in veterinary medicine for the control of primary bone tumors, the use of newer, more complicated surgeries such as limb sparing may be considered controversial. In this article, amputation and limb sparing are discussed with reference to case selection, outcome, and possible complications.

Entities:  

Mesh:

Year:  1996        PMID: 8825572     DOI: 10.1016/s0195-5616(96)50012-4

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  5 in total

1.  An ethicist's commentary on the case of the bull mastiff with osteosarcoma.

Authors:  F Barton
Journal:  Can Vet J       Date:  1997-09       Impact factor: 1.008

2.  Accuracy of computed tomography in determining lesion size in canine appendicular osteosarcoma.

Authors:  Ketaki S Karnik; Valerie F Samii; Steven E Weisbrode; Cheryl A London; Eric M Green
Journal:  Vet Radiol Ultrasound       Date:  2012-03-14       Impact factor: 1.363

Review 3.  Prognostic factors in canine appendicular osteosarcoma - a meta-analysis.

Authors:  Ilse Boerman; Gayathri T Selvarajah; Mirjam Nielen; Jolle Kirpensteijn
Journal:  BMC Vet Res       Date:  2012-05-15       Impact factor: 2.741

Review 4.  What do we know about canine osteosarcoma treatment? Review.

Authors:  M Szewczyk; R Lechowski; K Zabielska
Journal:  Vet Res Commun       Date:  2014-11-26       Impact factor: 2.459

5.  Prognostic value of fluorine18 flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma.

Authors:  Lynn R Griffin; Douglas H Thamm; Ariel Brody; Laura E Selmic
Journal:  J Vet Intern Med       Date:  2019-02-15       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.